Compagnie Mercosur Grecemar has decided to expand its operations into the Medical Cannabis Industry.
"Grecemar has acquired 100% of the outstanding shares of the three companies based in Uruguay that make up this project, which will be developed in accordance with the regulations of the Uruguayan authorities," the team with the company explains. "All the necessary means for cultivation, medical range conception and distribution are based in Uruguay."
The Company’s subsidiaries were granted comprehensive licenses in February 2020 both for the cultivation of cannabis and for the production of pharmaceutical grade products derived from cannabis.
"The company is launching a vertically integrated project for a large scale, indoor based grow operating as well as industrial scale cannabis production focused exclusively on a wide range of pharmaceutical cannabis-based products," they further explain.
Compagnie Mercosur Grecemar President Miguel Loinaz commented: “We are happy to divest our Company’s activity in a promising pharmaceutical project and we have full confidence in the advantages that Uruguay brings us as a country in which to base our operations thanks to its political, economic and legal stability.”
For more information:
Grecemar Biological Resources
6 Place de la Madeleine,FR-75008 Paris, France
06 60 78 42 82
[email protected]
grecemar.com